Benefits of Sunlight: A Bright Spot for Human Health by Mead, M. Nathaniel
Environews | FocusEnvironmental Health Perspectives • VOLUME 116 | NUMBER 4 | April 2008 A 161
P
l
a
i
n
v
i
e
w
/
i
S
t
o
c
k
p
h
o
t
o
Benefits of Sunlight
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ABright Spot forHuman Health
E
ach day, Apollo’s fiery chariot makes its
way across the sky, bringing life-giving
light to the planet. For the ancient Greeks
and Romans, Apollo was the god of medicine
and healing as well as of sun and light—but
Apollo could bring sickness as well as cure.
Today’s scientists have come to a similarly
dichotomous recognition that exposure to the
ultraviolet radiation (UVR) in sunlight has
both beneficial and deleterious effects on
human health. 
Most public health messages of the past
century have focused on the hazards of too
much sun exposure. UVA radiation (95–97%
of the UVR that reaches Earth’s surface) pene-
trates deeply into the skin, where it can con-
tribute to skin cancer indirectly via generation
of DNA-damaging molecules such as hydroxyl
and oxygen radicals. Sunburn is caused by too
much UVB radiation; this form also leads to
direct DNA damage and promotes various
skin cancers. Both forms can damage collagen
fibers, destroy vitamin A in skin, accelerate
aging of the skin, and increase the risk of skin
cancers. Excessive sun exposure can also cause
cataracts and diseases aggravated by UVR-
induced immunosuppression such as reactiva-
tion of some latent viruses. 
However, excessive UVR exposure
accounts for only 0.1% of the total global
burden of disease in disability-adjusted life
years (DALYs), according to the 2006 World
Health Organization (WHO) report The
Global Burden of Disease Due to Ultraviolet
Radiation. DALYs measure how much a per-
son’s expectancy of healthy life is reduced by
premature death or disability caused by dis-
ease. Coauthor Robyn Lucas, an epidemiolo-
gist at the National Centre for Epidemiology
and Population Health in Canberra,
Australia, explains that many diseases linked
to excessive UVR exposure tend to be rela-
tively benign—apart from malignant
melanoma—and occur in older age groups, due
mainly to the long lag between exposure and
manifestation, the requirement of cumulativeexposures, or both. Therefore, when meas-
uring by DALYs, these diseases incur a
relatively low disease burden despite their
high prevalence.
In contrast, the same WHO report noted
that a markedly larger annual disease burden
of 3.3 billion DALYs worldwide might result
from very low levels of UVR exposure. This
burden subsumes major disorders of the
musculoskeletal system and possibly an
increased risk of various autoimmune dis-
eases and life-threatening cancers.
The best-known benefit of sunlight is its
ability to boost the body’s vitamin D sup-
ply; most cases of vitamin D deficiency are
due to lack of outdoor sun exposure. At least
1,000 different genes governing virtually
every tissue in the body are now thought to
be regulated by 1,25-dihydroxyvitamin D3
(1,25[OH]D), the active form of the vita-
min, including several involved in calcium
metabolism  and neuromuscular and
immune system functioning. 
Although most of the health-promoting
benefits of sun exposure are thought to occur
through vitamin D photosynthesis, there
may be other health benefits that have gone
largely overlooked in the debate over how
much sun is needed for good health [see
“Other Sun-Dependent Pathways,” p. A165].
As for what constitutes “excessive” UVR
exposure, there is no one-size-fits-all answer,
says Lucas: “‘Excessive’ really means inappro-
priately high for your skin type under a
particular level of ambient UVR.” 
Vitamin D Production
Unlike other essential vitamins, which
must be obtained from food, vitamin D
can be synthesized in the skin through a
photosynthetic reaction triggered by expo-
sure to UVB radiation. The efficiency of
production depends on the number of UVB
photons that penetrate the skin, a process
that can be curtailed by clothing, excess
body fat, sunscreen, and the skin pigment
melanin. For most white people, a half-hour
in the summer sun in a bathing suit can ini-
tiate the release of 50,000 IU (1.25 mg)
vitamin D into the circulation within 24
hours of exposure; this same amount of
exposure yields 20,000–30,000 IU in
tanned individuals and 8,000–10,000 IU in
dark-skinned people.
The initial photosynthesis produces vita-
min D3, most of which undergoes additional
transformations, starting with the produc-
tion of 25-hydroxyvitamin D (25[OH]D),
the major form of vitamin D circulating in
the bloodstream and the form that is rou-
tinely measured to determine a person’s
vitamin D status. Although various cell
types within the skin can carry out this
transformation locally, the conversion takes
place primarily in the liver. Another set of
transformations occurs in the kidney and
other tissues, forming 1,25(OH)D. This
form of the vitamin is actually a hormone,
chemically akin to the steroid hormones. 
1,25(OH)D accumulates in cell nuclei of
the intestine, where it enhances calcium and
phosphorus absorption, controlling the flow
of calcium into and out of bones to regulate
bone-calcium metabolism. Michael Holick, a
medical professor and director of the Bone
Health Care Clinic at Boston University
Medical Center, says, “The primary physio-
logic function of vitamin D is to maintain
serum calcium and phosphorous levels with-
in the normal physiologic range to support
most metabolic functions, neuromuscular
transmission, and bone mineralization.” 
Without sufficient vitamin D, bones
will not form properly. In children, this
causes rickets, a disease characterized by
growth retardation and various skeletal
deformities, including the hallmark bowed
legs. More recently, there has been a grow-
ing appreciation for vitamin D’s impact
on bone health in adults. In August 2007,
the Agency for Health Care Policy and
Research published Effectiveness and Safety
of Vitamin D in Relation to Bone Health, a
systematic review of 167 studies that found
“fair evidence” of an association between
circulating 25(OH)D concentrations and
either increased bone-mineral density or
reduced falls in older people (a result of
strengthened muscles as well as strength-
ened bones). “Low vitamin D levels will
precipitate and exacerbate osteoporosis in
both men and women and cause the painful
bone disease osteomalacia,” says Holick. 
Evolution of the Great Solar Debate
In the 2002 book Bone Loss and Osteoporosis
in Past Populations: An Anthropological
Perspective, Reinhold Vieth, a nutrition pro-
fessor at the University of Toronto, writes
that early primates probably acquired their
relatively high vitamin D requirements
from frequent grooming and ingestion of
oils rich in vitamin D precursors that were
secreted by their skin onto their fur. The
first humans evolved in equatorial Africa,
where the direct angle of sunlight delivers
very strong UVR most of the year. The
gradual loss of protective fur may have cre-
ated evolutionary pressure to develop deeply
pigmented skin to avoid photodegradation
of micronutrients and protect sweat glands
from UVR-induced injury.
In the July 2000 issue of the Journal of
Human Evolution, California Academy of
Sciences anthropologists Nina Jablonski and
George Chaplin wrote that because dark skin
requires about five to six times more solar
exposure than pale skin for equivalent
vitamin D photosynthesis, and because the
intensity of UVB radiation declines with
increasing latitude, one could surmise that
skin lightening was an evolutionary adapta-
tion that allowed for optimal survival in low-
UVR climes, assuming a traditional diet and
outdoor lifestyle. Cooler temperatures in
these higher latitudes resulted in the need for
more clothing and shelter, further reducing
UVR exposure. With shorter winter days
and insufficient solar radiation in the UVB
wavelengths needed to stimulate vitamin D
synthesis, dietary sources such as fatty fish
became increasingly important.
Over time, clothing became the norm in
higher latitudes and then eventually a social
attribute in many societies. By the 1600s,
peoples in these regions covered their whole
body, even in summertime. Many children
who lived in the crowded and polluted
industrialized cities of northern Europe
developed rickets. By the late 1800s,
approximately 90% of all children living in
industrialized Europe and North America
had some manifestations of the disease,
according to estimates based on autopsy
studies of the day cited by Holick in the
August 2006 Journal of Clinical Investiga-
tion and the October 2007 American
Journal of Public Health. 
Doctors throughout Europe and North
America began promoting whole-body sun-
bathing to help prevent rickets. It was also
recognized that wintertime sunlight in the
temperate zone was too feeble to prevent
rickets. For this reason, many children were
exposed to UVR from a mercury or carbon
arc lamp for one hour three times a week,
which proved to be an effective preventive
measure and treatment.
Around the time the solar solution to
rickets gained widespread traction in medical
circles, another historic scourge, tuberculosis
(TB), was also found to respond to solar
intervention. TB patients of all ages were sent
to rest in sunny locales and generally returned
in good health. Dermatology professor
Barbara A. Gilchrest of Boston University
School of Medicine says that, whereas sun
exposure was shown to improve cutaneous
TB, sanatorium patients with pulmonary TB
likely responded as much or more to rest and
good nutrition than to UVR. Nevertheless, a
meta-analysis published in the February 2008
International Journal of Epidemiology found
that high vitamin D levels reduce the risk of
active TB (i.e., TB showing clinical symp-
toms) by 32%.
Almost overnight, as awareness of the
sun’s power against rickets and TB spread,
attitudes toward sun exposure underwent a
radical shift. The suntan became valued in
the Western world as a new status symbol
that signified both health and wealth, as
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only the affluent could afford to vacation
by the sea and play outdoor sports. Photo-
therapy quickly emerged as a popular med-
ical treatment not only for TB, but also for
rheumatic disorders, diabetes, gout, chronic
ulcers, and wounds. The “healthy tan” was
in, and “sickly-looking” pale skin was out.
Cancer: Cause, Protection, or Both?
The first reports of an association between
sun exposure and skin cancer began to sur-
face in dermatology publications in the late
nineteenth century. Nevertheless, it was not
until the 1930s that the U.S. Public Health
Service began issuing warnings about sun-
related health risks. People were cautioned
to avoid the midday summer sun, cover
their heads in direct sunlight, and gradually
increase the time of sun exposure from an
initial 5–10 minutes per day to minimize
the risk of sunburn.
In the decades that followed, the skin
cancer hazards of excessive sun exposure
would be extensively studied and mapped.
Today, the three main forms of skin can-
cer—melanoma, basal cell carcinoma, and
squamous cell carcinoma—are largely
attributed to excessive UVR exposure. Skin
cancers became the most common form of
cancer worldwide, especially among groups
such as white residents of Australia and
New Zealand. 
When atmospheric scientists first called
attention to possible chemical destruction
of the stratospheric ozone layer in the early
1970s, one predicted consequence of the
increased UVB radiation was a rise in skin
cancer rates, especially in Australia, New
Zealand, South Africa, and Latin America.
To counter this threat, the WHO, the
United Nations Environment Programme,
the World Meteorological Organization,
the International Agency for Research on
Cancer, and the International Commission
on Non-Ionizing Radiation Protection
established INTERSUN, the Global UV
Project, with the express goal of reducing
the burden of UVR-related disease.
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s diurnal creatures, we humans are programmed to be out-
doors while the sun is shining and home in bed at night. This
is why melatonin is produced during the dark hours and stops upon
optic exposure to daylight. This pineal hormone is a key pacesetter
for many of the body’s circadian rhythms. It also plays an important
role in countering infection, inflammation, cancer, and auto-
immunity, according to a review in the May 2006 issue of Current
Opinion in Investigational Drugs. Finally, melatonin suppresses
UVR-induced skin damage, according to research in the July 2005
issue of Endocrine.
When people are exposed to sunlight or very bright artificial
light in the morning, their nocturnal melatonin production occurs
sooner, and they enter into sleep more easily at night. Melatonin
production also shows a seasonal variation relative to the availability
of light, with the hormone produced for a longer period in the win-
ter than in the summer. The melatonin rhythm phase advancement
caused by exposure to bright morning light has been effective
against insomnia, premenstrual syndrome, and seasonal affective
disorder (SAD).
The melatonin precursor, serotonin, is also affected by exposure
to daylight. Normally produced during the day, serotonin is only
converted to melatonin in darkness. Whereas high melatonin levels
correspond to long nights and short days, high serotonin levels in
the presence of melatonin reflect short nights and long days (i.e.,
longer UVR exposure). Moderately high serotonin levels result in
more positive moods and a calm yet focused mental outlook.
Indeed, SAD has been linked with low serotonin levels during the
day as well as with a phase delay in nighttime melatonin produc-
tion. It was recently found that mammalian skin can produce sero-
tonin and transform it into melatonin, and that many types of skin cells express receptors for both serotonin and melatonin.
With our modern-day penchant for indoor activity and staying up well past dusk, nocturnal melatonin production is typically far
from robust. “The light we get from being outside on a summer day can be a thousand times brighter than we’re ever likely to experi-
ence indoors,” says melatonin researcher Russel J. Reiter of the University of Texas Health Science Center. “For this reason, it’s impor-
tant that people who work indoors get outside periodically, and moreover that we all try to sleep in total darkness. This can have a
major impact on melatonin rhythms and can result in improvements in mood, energy, and sleep quality.” 
For people in jobs in which sunlight exposure is limited, full-spectrum lighting may be helpful. Sunglasses may further limit the
eyes’ access to full sunlight, thereby altering melatonin rhythms. Going shades-free in the daylight, even for just 10–15 minutes, could
confer significant health benefits. 
Serotonin, Melatonin, and DaylightINTERSUN activities have included the
development of an internationally recog-
nized UV Index to help frame sun protec-
tion messages related to the daily intensity
of UVR. [For more information on these
activities, see “WHO Ultraviolet Radiation
Website,” p. A157 this issue.]
Australia was among the first countries
to spearhead large-scale sun protection pro-
grams, with the Slip-Slop-Slap initiative
(short for “slip on a shirt, slop on some sun-
screen, and slap on a hat”) introduced in
the early 1980s. “This program and the
subsequent SunSmart campaign have been
highly effective in informing Australians
of the risks and providing clear, practical
instructions as to how to avoid excessive
UVR exposure,” says Lucas. As a result
of increased use of hats, sunscreen, and
shade, the incidence of malignant melanoma
has begun to plateau in Australia, New
Zealand, Canada, and Northern Europe
among some age groups. However, because
other UVR-induced skin cancers typically
take longer than melanoma to develop,
their incidence rates continue to rise in
most developed countries. Lucas says a
gradual improvement in these rates is to be
expected as well. 
Whereas skin cancer is associated with
too much UVR exposure, other cancers
could result from too little. Living at higher
latitudes increases the risk of dying from
Hodgkin lymphoma, as well as breast, ovar-
ian, colon, pancreatic, prostate, and other
cancers, as compared with living at lower
latitudes. A randomized clinical trial by
Joan Lappe, a medical professor at
Creighton University, and colleagues, pub-
lished in the June 2007 issue of the American
Journal of Clinical Nutrition, confirmed that
taking 2–4 times the daily dietary reference
intake of 200–600 IU vitamin D3 and cal-
cium resulted in a 50–77% reduction in
expected incidence rates of all cancers
combined over a four-year period in post-
menopausal women living in Nebraska. 
Moreover, although excessive sun expo-
sure is an established risk factor for cutaneous
malignant melanoma, continued high sun
exposure was linked with increased survival
rates in patients with early-stage melanoma in
a study reported by Marianne Berwick, an
epidemiology professor at the University of
New Mexico, in the February 2005 Journal
of the National Cancer Institute. Holick also
points out that most melanomas occur on the
least sun-exposed areas of the body, and occu-
pational exposure to sunlight actually reduced
melanoma risk in a study reported in the June
2003 Journal of Investigative Dermatology. 
Other Health Links
Various studies have linked low 25(OH)D
levels to diseases other than cancer, raising
the possibility that vitamin D insufficiency
is contributing to many major illnesses. For
example, there is substantial though not
definitive evidence that high levels of vita-
min D either from diet or from UVR
exposure may decrease the risk of develop-
ing multiple sclerosis (MS). Populations at
higher latitudes have a higher incidence and
prevalence of MS; a review in the December
2002 issue of Toxicology by epidemiology
professor Anne-Louise Ponsonby and col-
leagues from The Australian National
University revealed that living at a latitude
above 37° increased the risk of developing
MS throughout life by greater than 100%. 
Still to be resolved, however, is the ques-
tion of what levels of vitamin D are optimal
for preventing the disease—and whether the
statistical associations reflect different gene
pools rather than different levels of
25(OH)D. (Interestingly, Holick reported in
the August 1988 issue of The Journal of
Clinical Endocrinology & Metabolism that no
previtamin D3 formed when human skin
was exposed to sunlight on cloudless days in
Boston, at 42.2°N, from November through
February or in Edmonton, at 52°N, from
October through March.)
“Scientific evidence on specific effects of
vitamin D in preventing MS or slowing its
progression is not sufficient,” says Alberto
Ascherio, a nutritional epidemiologist at the
Harvard School of Public Health. “Never-
theless, considering the safety of vitamin D
even in high doses, there is no clear contra-
indication, and because vitamin D deficiency
is very prevalent, especially among MS
patients, taking vitamin D supplements and
getting moderate sun exposure is more likely
to be beneficial than not.” 
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Personal UVB dose and risk of several types of cancer both depend in part on latitude of residence. These maps show a striking concor-
dance between differential UVB dose across the United States and mortality rates of breast cancer among white women.
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As with MS, there appears to be a latitu-
dinal gradient for type 1 diabetes, with a
higher incidence at higher latitudes. A
Swedish epidemiologic study published in the
December 2006 issue of Diabetologia found
that sufficient vitamin D status in early life
was associated with a lower risk of developing
type 1 diabetes. Nonobese mice of a strain
predisposed to develop type 1 diabetes
showed an 80% reduced risk of developing
the disease when they received a daily dietary
dose of 1,25(OH)D, according to research
published in the June 1994 issue of the same
journal. And a Finnish study published
3 November 2001 in The Lancet showed that
children who received 2,000 IU vitamin D
per day from 1 year of age on had an 80%
decreased risk of developing type 1 diabetes
later in life, whereas children who were vita-
min D deficient had a fourfold increased risk.
Researchers are now seeking to understand
how much UVR/vitamin D is needed to
lower the risk of diabetes and whether this is
a factor only in high-risk groups.
There is also a connection with metabolic
syndrome, a cluster of conditions that
increases one’s risk for type 2 diabetes and
cardiovascular disease. A study in the Sep-
tember 2006 issue of Progress in Biophysics
and Molecular Biology demonstrated that in
young and elderly adults, serum 25(OH)D
was inversely correlated with blood glucose
concentrations and insulin resistance. Some
studies have demonstrated high prevalence of
low vitamin D levels in people with type 2
diabetes, although it is not clear whether this
is a cause of the disease or an effect of another
causative factor—for example, lower levels of
physical activity (in this case, outdoor activity
in particular).
People living at higher latitudes through-
out the world are at higher risk of hyperten-
sion, and patients with cardiovascular disease
are often found to be deficient in vitamin D,
according to research by Harvard Medical
School professor Thomas J. Wang and col-
leagues in the 29 January 2008 issue of
Circulation. “Although the exact mechanisms
are poorly understood, it is known that
1,25(OH)D is among the most potent hor-
mones for down-regulating the blood pressure
hormone renin in the kidneys,” says Holick.
“Moreover, there is an inflammatory compo-
nent to atherosclerosis, and vascular smooth
muscle cells have a vitamin D receptor and
relax in the presence of 1,25(OH)D, suggest-
ing a multitude of mechanisms by which vita-
min D may be cardioprotective.”
To determine the potential link betwen
sun exposure and the protective effect in pre-
venting hypertension, Rolfdieter Krause of
the Free University of Berlin Department of
Natural Medicine and colleagues exposed a
group of hypertensive adults to a tanning bed
that emitted full-spectrum UVR similar to
summer sunlight. Another group of hyperten-
sive adults was exposed to a tanning bed that
emitted UVA-only radiation similar to winter
sunlight. After three months, those who used
the full-spectrum tanning bed had an average
180% increase in their 25(OH)D levels and
an average 6 mm Hg decrease in their systolic
and diastolic blood pressures, bringing them
into the normal range. In constrast, the group
that used the UVA-only tanning bed showed
no change in either 25(OH)D or blood pres-
sure. These results were published in the
29 August 1998 issue of The Lancet.
According to Krause, who currently heads the
Heliotherapy Research Group at the Medical
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Other Sun-Dependent Pathways
T
he sun may be best known for boosting production of vitamin D, but there are
many other UVR-mediated effects independent of this pathway.
Direct immune suppression. Exposure to both UVA and UVB radiation can have direct
immunosuppressive effects through upregulation of cytokines (TNF-α and IL-10) and
increased activity of T regulatory cells that remove self-reactive T cells. These mecha-
nisms may help prevent autoimmune diseases. 
Alpha melanocyte-stimulating hormone (α α-MSH). Upon exposure to sunshine,
melanocytes and keratinocytes in the skin release α-MSH, which has been implicated in
immunologic tolerance and suppression of contact hypersensitivity. α-MSH also helps
limit oxidative DNA damage resulting from UVR and increases gene repair, thus reduc-
ing melanoma risk, as reported 15 May 2005 in Cancer Research. 
Calcitonin gene-related peptide (CGRP). Released in response to both UVA and UVB
exposure, this potent neuropeptide modulates a number of cytokines and is linked
with impaired induction of immunity and the development of immunologic toler-
ance. According to a report in the September 2007 issue of Photochemistry and
Photobiology, mast cells (which mediate hypersensitivity reactions) play a critical role
in CGRP-mediated immune suppression. This could help explain sunlight’s efficacy in
treating skin disorders such as psoriasis.
Neuropeptide substance P. Along with CGRP, this neuropeptide is released from senso-
ry nerve fibers in the skin following UVR exposure. This results in increased lymphocyte
proliferation and chemotaxis (chemically mediated movement) but may also produce
local immune suppression.
Endorphins. UVR increases blood levels of natural opiates called endorphins.
Melanocytes in human skin express a fully functioning endorphin receptor system,
according to the June 2003 Journal of Investigative Dermatology, and a study pub-
lished 24 November 2005 in Molecular and Cellular Endocrinology suggests that the
cutaneous pigmentary system is an important stress-response element of the skin.University of Berlin, a serum 25(OH)D level
of at least 40 ng/mL should be adequate to
protect against hypertension and other forms
of cardiovascular disease (as well as cancers of
the prostate and colon).
William Grant, who directs the Sunlight,
Nutrition, and Health Research Center, a
research and education organization based in
San Francisco, suspects that sun exposure
and higher 25(OH)D levels may confer pro-
tection against other illnesses such as
rheumatoid arthritis (RA), asthma, and
infectious diseases. “Vitamin D induces
cathelicidin, a polypeptide that effectively
combats both bacterial and viral infections,”
Grant says. “This mechanism explains much
of the seasonality of such viral infections as
influenza, bronchitis, and gastroenteritis, and
bacterial infections such as tuberculosis and
septicemia.” For example, RA is more severe
in winter, when 25(OH)D levels tend to be
lower, and is also more prevalent in the high-
er latitudes. In addition, 25(OH)D levels are
inversely associated with the clinical status of
RA patients, and greater intake of vitamin D
has been linked with lower RA risk, as
reported in January 2004 in Arthritis &
Rheumatism.  
Some reports, including an article in the
October–December 2007 issue of Acta
Medica Indonesiana, indicate that sufficient
1,25(OH)D inhibits induction of disease in
RA, collagen-induced arthritis, Lyme arthri-
tis, autoimmune encephalomyelitis, thyroidi-
tis, inflammatory bowel disease, and systemic
lupus erythematosus. Nonetheless, interven-
tional data are lacking for most autoimmune
disorders and infectious diseases, with the
exception of TB.
How Much Is Enough?
Gilchrest points out a problem with the lit-
erature: “Everyone recommends something
different, depending on the studies with
which they are most aligned. One study
reports an increased risk of prostate cancer for
men with 25(OH)D levels above 90 ng/mL,
for example.” In the June 2007 Lappe arti-
cle, she notes, subjects in the control “high-
risk” unsupplemented group had 25(OH)D
levels of 71 nmol/L and the supplemented
group had levels of 96 nmol/L. 
Nevertheless, given the epidemiologic
backdrop described above, there are now
calls to rethink sun exposure policy or to
promote vitamin D supplementation in
higher-risk populations. Such groups include
pregnant or breastfeeding women (these
states draw upon a mother’s own reserves of
vitamin D), the elderly, and those who must
avoid the sun. Additionally, solely breastfed
infants whose mothers were vitamin D defi-
cient during pregnancy have smaller reserves
of the nutrient and are at greater risk of
developing rickets. Even in the sun-rich
environment of the Middle East, insufficient
vitamin D is a severe problem among breast-
fed infants of women who wear a burqa (a
traditional garment that covers the body
from head to foot), as reported in the
February 2003 Journal of Pediatrics. 
Several recent reports indicate an increase
in rickets particularly among breastfed black
infants, though white babies also are increas-
ingly at risk. A study in the February 2007
Journal of Nutrition concluded that black and
white pregnant women and neonates in the
northern United States are at high risk of
vitamin D insufficiency, even when mothers
take prenatal vitamins (which typically pro-
vide 100–400 IU vitamin D3). Studies by
Bruce Hollis, director of pediatric nutritional
sciences at the Medical University of South
Carolina, and colleagues suggest that a mater-
nal vitamin D3 intake of 4,000 IU per day is
safe and sufficient to ensure adequate vitamin D
status for both mother and nursing infant. 
These days, most experts define vitamin D
deficiency as a serum 25(OH)D level of less
than 20 ng/mL. Holick and others assert that
levels of 29 ng/mL or lower can be consid-
ered to indicate a relative insufficiency of
vitamin D. Using this scale and considering
various epidemiologic studies, an estimated
1 billion people worldwide have vitamin D
deficiency or insufficiency, says Holick, who
adds, “According to several studies, some
forty to one hundred percent of the U.S. and
European elderly men and women still living
in the community [that is, not in nursing
homes] are vitamin D deficient.” Holick
asserts that a large number of infants, chil-
dren, adolescents, and postmenopausal
women also are vitamin D insufficient.
“These individuals have no apparent skeletal
or calcium metabolism abnormalities but
may be at much higher risk of developing
various diseases,” Holick says. 
In the context of inadequate sunlight or
vitamin D insufficiency, some scientists
worry that the emphasis on preventing skin
cancers tends to obscure the much larger
mortality burden posed by more life-
threatening cancers such as lung, colon, and
breast cancers. Many studies have shown
that cancer-related death rates decline as one
moves toward the lower latitudes (between
37°N and 37°S), and that the levels of ambi-
ent UVR in different municipalities corre-
late inversely with cancer death rates there.
“As you head from north to south, you may
find perhaps two or three extra deaths [per
hundred thousand people] from skin can-
cer,” says Vieth. “At the same time, though,
you’ll find thirty or forty fewer deaths for
the other major cancers. So when you esti-
mate the number of deaths likely to be
attributable to UV light or vitamin D, it
does is not appear to be the best policy to
advise people to simply keep out of the sun
just to prevent skin cancer.” 
To maximize protection against cancer,
Grant recommends raising 25(OH)D levels
to between 40 and 60 ng/mL. Research such
as that described in Holick’s August 2006
Journal of Clinical Investigation article indi-
cates that simply keeping the serum level
above 20 ng/mL could reduce the risk of
cancer by as much as 30–50%. 
Cedric F. Garland, a medical professor
at the University of California, San Diego,
says that maintaining a serum level of
55–60 ng/mL may reduce the breast cancer
rate in temperate regions by half, and that
incidence of many other cancers would be
similarly reduced as well. He calls this “the
single most important action that could be
taken by society to reduce the incidence of
cancer in North America and Europe,
beyond not smoking.” Moreover, these levels
could be readily achieved by consuming no
more than 2,000 IU/day of vitamin D3 at a
cost of less than $20 per year and, unless
there are contraindications to sunlight expo-
sure, spending a few minutes outdoors
(3–15 minutes for whites and 15–30 minutes
for blacks) when the sun is highest in the
sky, with 40% of the skin area exposed. 
Holick, Vieth, and many other experts
now make a similar daily recommendation:
4,000 IU vitamin D3 without sun exposure
or 2,000 IU plus 12–15 minutes of midday
sun. They say this level is quite safe except for
sun-sensitive individuals or those taking
medications that increase photosensitivity.
Gilchrest says some sunlight enters the
skin even through a high-SPF sunscreen, so
people can maximize their dermal vitamin D
production by spending additional time out-
doors while wearing protection. “Without
the sunscreen, this same individual would be
incurring substantially more damage to her
skin but not further increasing her vitamin
D level,” she says.
Creating a Balanced Message
A growing number of scientists are con-
cerned that efforts to protect the public from
excessive UVR exposure may be eclipsing
recent research demonstrating the diverse
health-promoting benefits of UVR exposure.
Some argue that the health benefits of UVB
radiation seem to outweigh the adverse
effects, and that the risks can be minimized
by carefully managing UVR exposure (e.g.,
by avoiding sunburn), as well as by increas-
ing one’s intake of dietary antioxidants and
limiting dietary fat and caloric intake.
Antioxidants including polyphenols, api-
genin, curcumin, proanthocyanidins,
resveratrol, and silymarin have shown
promise in laboratory studies in protecting
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through antimutagenic or immune-
modulating mechanisms. 
Central to the emerging debate is the
issue of how to best construct public health
messages that highlight the pros and cons
of sun exposure in a balanced way. Such
messages must necessarily take into account
variations in skin pigmentation between
groups and these groups’ differing suscepti-
bilities to the dangers and benefits of sun
exposure. Moreover, says Patricia Alpert, a
nursing professor at the University of Las
Vegas, age matters. “The elderly [have a]
declining capacity to make vitamin D,” she
says. “Many elderly, especially those living
in nursing homes, are vitamin D deficient,
[even] those living in areas considered to
have adequate sunshine.”
Many experts are now recommending a
middle-ground approach that focuses on
modest sun exposures. Gilchrest says the
American Academy of Dermatology and
most dermatologists currently suggest sun
protection in combination with vitamin D
supplementation as a means of minimizing
the risk of both skin cancer and internal
cancers. Furthermore, brief, repeated expo-
sures are more efficient at producing
vitamin D. “Longer sun exposures cause
further sun damage to skin and increase the
risk of photo-aging and skin cancer, but
do not increase vitamin D production,”
she explains.
Lucas adds that people should use sun
protection when the UV Index is more
than 3. As part of Australia’s SunSmart
program, “UV Alerts” are announced in
newspapers throughout the country when-
ever the index is forecast to be 3 or higher.
“Perhaps,” she says, “this practice should
be extended to other nations as well.” U.S.
residents can obtain UV Index forecasts
through the EPA’s SunWise website
(http://epa.gov/sunwise/uvindex.html).
In the near future, vitamin D and health
guidelines regarding sun exposure may need
to be revised. But many factors not directly
linked to sun protection will also need to be
taken into account. “Current observations of
widespread vitamin D insufficiency should
not be attributed only to sun protection
strategies,” says Lucas. “Over the same period
there is a trend to an increasingly indoor
lifestyle, associated with technological
advances such as television, computers, and
video games.” She says sun-safe messages
remain important—possibly more so than
ever before—to protect against the poten-
tially risky high-dose intermittent sun
exposure that people who stay indoors may
be most likely to incur.
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Research Challenges
G
rowing evidence of the beneficial effects of UVR exposure has challenged
the sun-protection paradigm that has prevailed for decades. Before a sun-
exposure policy change occurs, however, we need to know if there is enough evi-
dence to infer a protective effect of sun exposure against various diseases. 
Only through well-designed randomized clinical trials can cause-and-effect
relationships be established. However, most sunlight-related epidemiologic
research to date has relied on observational data that are subject to considerable
bias and confounding. Findings from observational studies are far less rigorous
and reliable than those of interventional studies. But interventional studies would
need to be very large and carried out over several decades (since most UVR-
mediated diseases occur later in life). Moreover, it is not at all clear when, over a
lifetime, sun exposure/vitamin D is most important. So for now scientists must rely
on the results of well-conducted observational analytic studies.
In sunlight-related research, there are two main exposures of interest: vitamin
D status, which is measured by the serum 25(OH)D level; and personal UVR dose,
which involves three fundamental factors: ambient UVR (a function of latitude,
altitude, atmospheric ozone levels, pollution, and time of year), amount of skin
exposed (a function of behavioral, cultural, and clothing practices), and skin pig-
mentation (with dark skin receiving a smaller effective dose to underlying struc-
tures than light skin).
When measuring sun exposure at the individual level, many scientists have
relied on latitude or ambient UVR of residence. But these measures are fraught
with uncertainties. “While ambient UVR varies, . . . so too do a variety of other
possible etiological factors, including diet, exposure to infectious agents, tempera-
ture, and possibly even physical activity levels,” says Robyn Lucas, an epidemiolo-
gist at Australia’s National Centre for Epidemiology and Population Health.
“Additionally, under any level of ambient UVR, the personal UV dose may vary
greatly. In short, there is no real specificity for ambient UVR.” 
Researchers also assess history of time in the sun at various ages, history of
sunburns, dietary and supplemental vitamin D intake, and other proxy measures.
Nonetheless, says Lucas, “there are drawbacks to inferring that a relationship with
any proxy for the exposure of interest is a relationship with personal UV dose or
vitamin D status.” On the bright side, she adds, our ability to accurately gauge an
individual’s UV dose history has been enhanced with the use of silicone rubber
casts of the back of subjects’ hands. The fine lines recorded by the cast provide an
objective measure of cumulative sun damage.
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